As shown by a large number of studies, inhibition of autophagy, accompanied with decreased expression of ATG5, has been an effective strategy to overcome acquired resistance in non‐small cell lung cancer [31], hepatocellular carcinoma [32] and breast cancer [33]. Here, ATG5 is linked to hepatocellular carcinoma.